Chen‐Ying Liu
Impact in
- Cell Biology top 0.5%
- Hippo pathway signaling and YAP/TAZ
- Cellular Mechanics and Interactions
- Molecular Biology top 5%
- Wnt/β-catenin signaling in development and cancer
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Wnt/β-catenin signaling in development and cancer 7
- Cancer-related gene regulation 6
- Ubiquitin and proteasome pathways 6
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 4
- Cell Biology 22
- Hippo pathway signaling and YAP/TAZ 19
- Co-authors
- Qun‐Ying Lei (7 shared papers)Kun‐Liang Guan (6 shared papers)Bin Zhao (2 shared papers)Yue Xiong (5 shared papers)Long Cui (27 shared papers)Zhengyu Zha (3 shared papers)Shimin Zhao (3 shared papers)Q. Richard Lu (1 shared paper)
- Journals
- Journal of Biological Chemistry (6 papers)Nature Communications (3 papers)Advanced Science (3 papers)Oncogene (3 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Chen‐Ying Liu
55 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Cell Biology 1.8k
- Molecular Biology 1.8k
- Cancer Research 361
- Geriatrics and Gerontology 92
- Oncology 498
Countries citing papers authored by Chen‐Ying Liu
This map shows the geographic impact of Chen‐Ying Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Ying Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Ying Liu more than expected).
Fields of papers citing papers by Chen‐Ying Liu
This network shows the impact of papers produced by Chen‐Ying Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Ying Liu. The network helps show where Chen‐Ying Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen‐Ying Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein Hit paper breakdown → | 2011 | 543 |
| 2 | 2009 | 459 | |
| 3 | 2010 | 435 | |
| 4 | 2018 | 140 | |
| 5 | 2012 | 134 | |
| 6 | 2015 | 113 | |
| 7 | 2010 | 111 | |
| 8 | 2014 | 76 | |
| 9 | 2019 | 58 | |
| 10 | 2020 | 57 | |
| 11 | 2018 | 50 | |
| 12 | 2014 | 48 | |
| 13 | 2020 | 47 | |
| 14 | 2020 | 45 | |
| 15 | 2020 | 45 | |
| 16 | 2015 | 45 | |
| 17 | 2016 | 44 | |
| 18 | 2017 | 43 | |
| 19 | 2020 | 43 | |
| 20 | 2020 | 40 |
About Chen‐Ying Liu
Chen‐Ying Liu is a scholar working on Molecular Biology, Cell Biology, Oncology, Immunology and Pathology and Forensic Medicine, having authored 56 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (19 papers), Wnt/β-catenin signaling in development and cancer (7 papers), Genetic factors in colorectal cancer (6 papers), Cancer-related gene regulation (6 papers), Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Inflammatory Bowel Disease (4 papers). The work is most often cited by research in Cell Biology (1.8k citations), Molecular Biology (1.8k citations), Cancer Research (361 citations), Geriatrics and Gerontology (92 citations) and Oncology (498 citations). Chen‐Ying Liu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Qun‐Ying Lei, Kun‐Liang Guan, Bin Zhao, Yue Xiong, Long Cui, Zhengyu Zha, Shimin Zhao, Q. Richard Lu, Li Li and Wei Huang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications, Advanced Science, Oncogene and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.